Acute dystonia by droperidol during intravenous patient-controlled analgesia in young patients. by Park, Chang Kil et al.
INTRODUCTION
Patient-controlled analgesia (PCA) has become an impor-
tant means for postoperative analgesia with parenteral opi-
oid. However, postoperative nausea and vomiting (PONV)
remains a major problem with a PCA system. Droperidol has
been used in PCA in the prevention of PONV (1). Although
usually well tolerated, it has been reported to cause extrapyra-
midal reactions (2-6). The side reactions are reported when
droperidol was injected intravenously (3-5), intramuscularly
(2), and epidurally (6). A rapidly developing and severe hyper-
tonic syndrome after an intravenous administration of droperi-




A 14-yr-old, 55-kg boy, ASA classification 1, was admitted
to our hospital because of a pathologic fracture on the distal
radius, left. He was planned to undergo an open reduction
with a plate and bone graft from iliac crest for the correction
of fracture. The patient received 1.0 mg of midazolam intra-
venously before anesthesia in the operating room. Intersca-
lene and axillary block were performed with 10 and 20 mL
each of 2% lidocaine, 0.5% bupivacaine, and saline in a ratio
of 2:1:1 mixed with epinephrine 1:200,000. For a bone graft
from the iliac crest, spinal anesthesia was performed with 11
mg of 0.5% bupivacaine (heavy Marcaine
�) at the L4-5 inter-
space. Loss of pinprick sensation extended to the T4 derma-
tome. During anesthesia, hypotension with bradycardia oc-
curred, and 4 mg of ephedrine and 0.1 mg of glycopyrrolate
were administered intravenously. Surgical procedure was un-
eventful. The total anesthetic time was 2 hr and 50 min. In
the recovery room, an initial bolus of 60  g of fentanyl was
injected intravenously followed by 1,340  g (25  g/kg) of
fentanyl with 2.2 mg (40  g/kg) of droperidol and 5% glu-
cose in a total volume of 98 mL using a continuous IV infuser,
Accufuser PLUS
� (basal, 2 mL/hr; bolus, 0.5 mL; lockout
interval, 15 min). On postoperative day (POD) 1, at 2 p.m.,
he vomited several times. The PCA was discontinued and 2
L/min of O2 was administered via nose. The doses of fentanyl
and midazolam infused for 19 hr were approximately 530  g
and 0.9 mg respectively. The symptom was relieved a little
thereafter, however he refused further continuous analgegic
infusion. His past history revealed no motion sickness. On the
other hand, the orthopedic surgeon had already prescribed 10
mg of prophylactic intravenous metoclopramide twice a day, 8
a.m. and 8 p.m., for PONV. Therefore the metoclopramide
that had been given before vomiting at 8 a.m. did not work.
At 7:30 p.m., we visited him and decided to give another
bolus of droperidol. He received 1.0 mg of droperidol intra-
venously at 8:10 p.m., just 10 min after the second admin-
istration of metoclopramide at 8 p.m. Approximately 20
min later, a hypertonic syndrome was developed, presenting
as opisthotonus, lateral flexion of the neck, and oculogyric
spasms with respiratory difficulty. He said “My extremities
are tightened up. My body get rigid and my legs become
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Acute Dystonia by Droperidol during Intravenous Patient-Controlled
Analgesia in Young Patients
Patient-controlled analgesia (PCA) is an important means for postoperative anal-
gesia with parenteral opioid. However, postoperative nausea and vomiting (PONV)
remains a major problem with a PCA system. Droperidol is used in PCA to pre-
vent PONV. Extrapyramidal reactions by droperidol are, however, occasionally
induced. We describe two cases of severe extrapyramidal hypertonic syndrome
with an intravenous administration of droperidol in PCA in young patients, follow-
ing orthopedic surgery. 
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flexed spontaneously. I have pains on my arms and legs. I can’t
close my eyes. My eyes deviate to the left side.” His eyes rotat-
ed upwards and to the left and seemed fixed in that position,
however he could move his eyes on command. Consciousness
did not seem to be impaired. Upon questioning, he answered
without difficulty in phonation. We consulted a neurologist
about his symptoms, and decided to observe him. Approxi-
mately 1.5 hr later, the rigidity was somewhat relieved. How-
ever, the rigidity of the legs occasionally reappeared over the
next 10 hr. The remainder of his postoperative course was un-
eventful. 
Patient 2
A 16-yr-old, 59-kg young patient, ASA classification 1,
was admitted because of a triplanar fracture on the ankle by
slipping down. He underwent open reduction and internal
fixation with plate and screw. The patient received 1.0 mg
of midazolam intravenously in the operating room. Spinal
anesthesia was performed with 12 mg of 0.5% bupivacaine
(heavy Marcaine
�) at L4-5 interspace. Loss of pinprick sensa-
tion extended to the T10 dermatome. The entire anesthetic
and surgical procedure, which lasted 2 hr and 40 min, was
uneventful. In the recovery room, an initial bolus of 50  g
of fentanyl was given intravenously followed by 1,150  g
(20  g/kg) of fentanyl with 4.7 mg (80  g/kg) of droperi-
dol and 5% glucose in a total volume of 98 mL using the
IV Accufuser PLUS
�(basal, 2 mL/hr; bolus, 0.5 mL; lockout
interval, 15 min). On POD 0 day, the patient complained
nausea, and the PCA was stopped. He was given 5 mg of
dexamethasone intravenously and nausea was relieved. Two
hours later, the PCA was restarted. On POD 2, no nausea or
vomiting was observed. He was asleep but responded to ver-
bal commands. On POD 2, 19 hr after the beginning of PCA,
an acute rigidity was developed on the whole body accom-
panied by grimacing, sweating and dyspnea. Consciousness
did not seem to be impaired. After 10 min, an intramuscu-
lar injection of 2 mg of midazolam was given to treat the
crisis and 3 L/min of O2 was administered via nasal prong.
Thirty minutes later, the symptom was markedly relieved.
However, the rigidity on abdomen still persisted. Two hours
and thirty minutes later, he was completely recovered from
the symptom. The doses of fentanyl and droperidol infused
for 17 hr were approximately 400  g and 1.7 mg respective-
ly. On POD 3, he was discharged without sequelae.
DISCUSSION
Extrapyramidal reactions to droperidol have been classified
in three groups (7): 1) acute dystonia, due to a hypertonicity
of the regional muscle groups, which involves spasm of mus-
cles of the tongue, face, neck, and back, and may be gener-
alized in forms of opisthotonus, scoliosis, and contractures
of the legs. In this case, consciousness is never impaired.; 2)
Parkinsonism, which includes bradykinesia, cog-wheel rigid-
ity, mask-like face, and tremor; and 3) akathisia, which can
be defined by motor restlessness, such as inability to sit still
and constant ambulation. 
Patient No. 1 experienced acute dystonia and recovered
spontaneously without sequelae. Although other forms exist
(5, 6), most extrapyramidal reactions caused by droperidol
are of the dystonic type (4). We suggest that the dystonia
was induced by the additional bolus injection of 1.0 mg of
droperidol on POD 1 with the residual effect of droperidol
via PCA from POD 0. Actually, the continuous intravenous
infusion of droperidol had been already stopped approximate-
ly 6 hr before the event. Droperidol has been reported to have
a terminal plasma half-life of about 2 hr (8). The action dura-
tion of droperidol lasts about 2 to 4 hr, although the alteration
of alertness may last 12 hr or longer (8). The droperidol that
had been already infused by PCA might have influenced the
occurrence of the attack. The adverse reactions to droperidol
are thought to be dose-related, however it do occur at low
doses, such as 0.65 mg of IV droperidol in adults (3). Chil-
dren are more susceptible to the effects of butyrophenones (2).
As droperidol, metoclopramide also has antidopaminergic
properties and may induce extrapyramidal tract signs (9). The
side reactions of metoclopramide have been reported as aka-
thisia (10-12), although other forms are seen (13, 14). Patient
No. 1 received metoclopramide at 8 a.m. on POD 1. There
was no evidence of akathisia-like syndrome in the patient.
Furthermore, there had been no suspicious signs related to
metoclopramide for 12 hr until the crisis developed. There-
fore we assume that the droperidol was the major cause of
the acute dystonia in the first patient, although the concur-
rent use of metoclopramide might have played a synergistic
role (15).
In patient No. 1, the hypertonic symptoms were noted 20
min after he had received 1.0 mg of droperidol intravenously.
Acute rigidity developed 19 hr after the beginning of PCA
in patient No. 2. The lapse of time between a single injec-
tion or a start of continuous infusion and the crisis is greatly
variable from few minutes after intravenous injection (4, 16)
to 14 hr after intramuscular injection (2), and the symptoms
can occur at any time.
We expected that the extrapyramidal reactions would hard-
ly occur in a continuous infusion of droperidol in PCA com-
pared to the bolus injection. Therefore, in patient No. 2, we
administered droperidol only in PCA without additional
bolus dose of the drug, although the dose of the drug was
two times higher in patient No. 2 than in patient No. 1 in-
stead. The dose of droperidol in patient No. 2 was calculat-
ed as 80  g/kg, whereas the recommended dose of the drug
in children is 10-50  g/kg (17). However, the recommended
dose of a bolus are not comparable with the actual dose of a
continuous 2-day infusion because of the different adminis-
tration method. Unexpectedly, acute dystonia also occurredin patient No. 2.
The treatment of acute dystonia in this clinical situation
has varied according to the authors. An intravenous adminis-
tration of 75 mg of diphenhydramine (Benadryl) was reported
to resolve all signs of the extrapyramidal reaction within 1
min (4), while that of 50 mg of the drug resolved symptoms
over the next 30 min (3). An intramuscular injection of dia-
zepam 0.16 or 0.17 mg/kg, chlorpromazine 0.4 mg/kg or
alimemazine 0.3 mg/ kg successfully treated the crisis (2). In
patient No. 1, the symptoms persisted for nearly 12 hr with-
out prescription. Fortunately, the patient was recovered spon-
taneously without any sequelae. In patient No. 2, however,
the reactions subsided within 30 min. This may be because
the intramuscular administration of midazolam contributed
to the resolution of the attack. Therefore, we suggest that a
definite treatment is necessary to terminate the extrapyrami-
dal reactions. Although neither of the patients experienced
sequelae, they considered the episodes to be quite distressing.
In summary, it is important to control extrapyramidal reac-
tions even during the continuous infusion of droperidol in
PCA, especially in juvenile patients. We have therefore decid-
ed to restrict the use and reduce the dose of droperidol in
young patients.
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